Healthcare provider profile · identity verified

Arleeta M Diggs, MD

Family Practice · MIDLOTHIAN, VA · NPI 1255366753

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	500	74
Sertraline Hcl	Sertraline Hcl	375	66
Amlodipine Besylate	Amlodipine Besylate	366	61
Quetiapine Fumarate	Quetiapine Fumarate	279	46
Atorvastatin Calcium	Atorvastatin Calcium	265	50
Donepezil Hcl	Donepezil Hcl	264	53
Losartan Potassium	Losartan Potassium	224	33
Memantine Hcl	Memantine Hcl	187	39
Escitalopram Oxalate	Escitalopram Oxalate	185	31
Furosemide	Furosemide	159	40
Gabapentin	Gabapentin	156	34
Bumetanide	Bumetanide	152	25
Famotidine	Famotidine	150	28
Omeprazole	Omeprazole	146	23
Trazodone Hcl	Trazodone Hcl	142	28
Metoprolol Tartrate	Metoprolol Tartrate	139	25
Pantoprazole Sodium	Pantoprazole Sodium	136	35
Eliquis	Apixaban	113	30
Potassium Chloride	Potassium Chloride	112	23
Metoprolol Succinate	Metoprolol Succinate	110	23
Buspirone Hcl	Buspirone Hcl	108	18
Carvedilol	Carvedilol	101	18
Latanoprost	Latanoprost	92	22
Mirtazapine	Mirtazapine	90	18
Montelukast Sodium	Montelukast Sodium	87	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	87	17
Clopidogrel	Clopidogrel Bisulfate	86	18
Lisinopril	Lisinopril	83	25
Lorazepam	Lorazepam	80	27
Rosuvastatin Calcium	Rosuvastatin Calcium	76	13
Hydrochlorothiazide	Hydrochlorothiazide	74	12
Simvastatin	Simvastatin	74	11
Spironolactone	Spironolactone	70	13
Midodrine Hcl	Midodrine Hcl	67	13
Citalopram Hbr	Citalopram Hydrobromide	66	11
Metformin Hcl	Metformin Hcl	65	16
Memantine Hcl Er	Memantine Hcl	59	suppressed
Risperidone	Risperidone	57	11
Divalproex Sodium	Divalproex Sodium	56	suppressed
Pravastatin Sodium	Pravastatin Sodium	56	suppressed
Duloxetine Hcl	Duloxetine Hcl	54	11
Carbidopa-Levodopa	Carbidopa/Levodopa	50	suppressed
Finasteride	Finasteride	50	11
Tramadol Hcl	Tramadol Hcl	50	17
Aripiprazole	Aripiprazole	49	suppressed
Diclofenac Sodium	Diclofenac Sodium	49	14
Nystatin	Nystatin	49	26
Fluoxetine Hcl	Fluoxetine Hcl	44	suppressed
Myrbetriq	Mirabegron	44	suppressed
Sucralfate	Sucralfate	44	suppressed
Bupropion Xl	Bupropion Hcl	42	suppressed
Loperamide	Loperamide Hcl	42	29
Warfarin Sodium	Warfarin Sodium	42	suppressed
Pregabalin	Pregabalin	40	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	40	32
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	11
Xarelto	Rivaroxaban	39	suppressed
Ezetimibe	Ezetimibe	38	suppressed
Propranolol Hcl	Propranolol Hcl	37	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	36	suppressed
Valsartan	Valsartan	36	suppressed
Fluticasone Propionate	Fluticasone Propionate	35	11
Alendronate Sodium	Alendronate Sodium	34	suppressed
Allopurinol	Allopurinol	33	suppressed
Levetiracetam	Levetiracetam	31	suppressed
Oxycodone Hcl	Oxycodone Hcl	30	suppressed
Timolol Maleate	Timolol Maleate	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Glimepiride	Glimepiride	29	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	13
Prednisone	Prednisone	29	17
Alprazolam	Alprazolam	28	suppressed
Atenolol	Atenolol	28	suppressed
Ondansetron Hcl	Ondansetron Hcl	28	18
Triamcinolone Acetonide	Triamcinolone Acetonide	28	18
Oxybutynin Chloride	Oxybutynin Chloride	27	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Metformin Hcl Er	Metformin Hcl	26	suppressed
Torsemide	Torsemide	26	suppressed
Lansoprazole	Lansoprazole	25	suppressed
Olanzapine	Olanzapine	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	23	12
Farxiga	Dapagliflozin Propanediol	23	suppressed
Lovastatin	Lovastatin	23	suppressed
Methenamine Hippurate	Methenamine Hippurate	23	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	22	suppressed
Clonazepam	Clonazepam	22	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Diltiazem Hcl	Diltiazem Hcl	22	suppressed
Estradiol	Estradiol	21	suppressed
Nebivolol Hcl	Nebivolol Hcl	21	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Pentoxifylline	Pentoxifylline	18	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	18	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	17	suppressed
Celecoxib	Celecoxib	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Folic Acid	Folic Acid	17	suppressed
Lumigan	Bimatoprost	17	suppressed
Methotrexate	Methotrexate Sodium	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	14
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Creon	Lipase/Protease/Amylase	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	14	suppressed
Cephalexin	Cephalexin	14	13
Nitrofurantoin	Nitrofurantoin Macrocrystal	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Alprazolam Xr	Alprazolam	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Haloperidol	Haloperidol	12	suppressed
Leucovorin Calcium	Leucovorin Calcium	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Trospium Chloride Er	Trospium Chloride	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Rivastigmine	Rivastigmine	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error